Drug Approval | April 21, 2026
Orbicular's partner secures tentative U.S. ANDA approval for a generic version of Ozempic
OneSource is the contract development and manufacturing organization (CDMO) partner for this product
OneSource is the contract development and manufacturing organization (CDMO) partner for this product
This includes 14.3 million views on YouTube and 9.8 million views on Meta platforms to amplify preventive heart health message
The study was conducted by PwC India in line with ISO 14040 and ISO 14044 protocols
The launch coincides with IBS Awareness Month in April
Marking three years of the National Diagnostics Catapult (NDxC), the conclave launched the Impact Report and unveiled environmental surveillance kits
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
At the core of Verida is Spectral Precise Image technology paired with a third-generation Nano-panel Precise dual-layer detector and an AI-based deep learning reconstruction engine
Medical experts point to a growing body of research linking energy drinks to liver injury
The approved product is a generic version of Ravicti, originally developed and marketed by Horizon Therapeutics
In his new role, Curtis will lead the formulation and execution of the company’s global technical strategy
Subscribe To Our Newsletter & Stay Updated
